[HTML][HTML] Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
CM Gay, CA Stewart, EM Park, L Diao, SM Groves… - Cancer cell, 2021 - cell.com
Despite molecular and clinical heterogeneity, small cell lung cancer (SCLC) is treated as a
single entity with predictably poor results. Using tumor expression data and non-negative …
single entity with predictably poor results. Using tumor expression data and non-negative …
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
CM Gay, CA Stewart, EM Park, L Diao… - Cancer …, 2021 - pubmed.ncbi.nlm.nih.gov
Despite molecular and clinical heterogeneity, small cell lung cancer (SCLC) is treated as a
single entity with predictably poor results. Using tumor expression data and non-negative …
single entity with predictably poor results. Using tumor expression data and non-negative …
[HTML][HTML] Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
CM Gay, CA Stewart, EM Park, L Diao, SM Groves… - Cancer Cell, 2021 - Elsevier
Despite molecular and clinical heterogeneity, small cell lung cancer (SCLC) is treated as a
single entity with predictably poor results. Using tumor expression data and non-negative …
single entity with predictably poor results. Using tumor expression data and non-negative …
[引用][C] Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
CM Gay, CA Stewart, EM Park, L Diao, SM Groves… - Cancer Cell, 2021 - cir.nii.ac.jp
Patterns of transcription factor programs and immune pathway activation define four major
subtypes of SCLC with distinct therapeutic vulnerabilities | CiNii Research CiNii 国立情報学 …
subtypes of SCLC with distinct therapeutic vulnerabilities | CiNii Research CiNii 国立情報学 …
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
CM Gay, CA Stewart, EM Park, L Diao… - Cancer …, 2021 - utsouthwestern.elsevierpure.com
Despite molecular and clinical heterogeneity, small cell lung cancer (SCLC) is treated as a
single entity with predictably poor results. Using tumor expression data and non-negative …
single entity with predictably poor results. Using tumor expression data and non-negative …
[HTML][HTML] Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
CM Gay, CA Stewart, EM Park, L Diao, SM Groves… - Cancer cell, 2021 - ncbi.nlm.nih.gov
Despite molecular and clinical heterogeneity, small cell lung cancer (SCLC) is treated as a
single entity with predictably poor results. Using tumor expression data and non-negative …
single entity with predictably poor results. Using tumor expression data and non-negative …
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
CM Gay, CA Stewart, EM Park, L Diao… - CANCER …, 2021 - iris.unicampania.it
Despite molecular and clinical heterogeneity, small cell lung cancer (SCLC) is treated as a
single entity with predictably poor results. Using tumor expression data and non-negative …
single entity with predictably poor results. Using tumor expression data and non-negative …
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
CM Gay, CA Stewart, EM Park, L Diao… - Cancer …, 2021 - mdanderson.elsevierpure.com
Despite molecular and clinical heterogeneity, small cell lung cancer (SCLC) is treated as a
single entity with predictably poor results. Using tumor expression data and non-negative …
single entity with predictably poor results. Using tumor expression data and non-negative …
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
CM Gay, CA Stewart, EM Park, L Diao, SM Groves… - paper.sciencenet.cn
美国德克萨斯大学MD 安德森癌症中心Lauren Averett Byers 团队的最新研究发现,
转录因子程序和免疫途径激活模式揭示了四种具有不同治疗脆弱性的小细胞肺癌(SCLC) 亚型 …
转录因子程序和免疫途径激活模式揭示了四种具有不同治疗脆弱性的小细胞肺癌(SCLC) 亚型 …
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities.
CM Gay, CA Stewart, EM Park, L Diao, SM Groves… - Cancer Cell, 2021 - europepmc.org
Despite molecular and clinical heterogeneity, small cell lung cancer (SCLC) is treated as a
single entity with predictably poor results. Using tumor expression data and non-negative …
single entity with predictably poor results. Using tumor expression data and non-negative …